ROCKWELL MEDICAL, INC.
For the period ended Dec 31, 2025. Filed Mar 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 26, 2026
RMTI$7.31-2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and 2024
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and par value amounts)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Cash and Cash Equivalents | $10,711 | $15,662 |
| Investments Available-for-Sale | 14,286 | 5,940 |
| Accounts Receivable, net | 8,143 | 8,291 |
| Inventory, net | 3,424 | 5,778 |
| Prepaid and Other Current Assets | 1,599 | 1,359 |
| Total Current Assets | 38,163 | 37,030 |
| Property and Equipment, net | 4,629 | 5,785 |
| Inventory - Non-Current | — | 178 |
| Right of Use Assets - Operating, net | 2,569 | 3,215 |
| Right of Use Assets - Finance, net | 651 | 1,344 |
| Intangible Assets, net | 9,656 | 10,207 |
| Goodwill | 921 | 921 |
| Other Non-Current Assets | 556 | 528 |
| Total Assets | $57,145 | $59,208 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Accounts Payable | $1,999 | $2,869 |
| Accrued Liabilities | 4,337 | 6,275 |
| Deferred Consideration - Current | 1,000 | 2,371 |
| Lease Liabilities - Operating - Current | 1,155 | 1,566 |
| Lease Liabilities - Finance - Current | 469 | 599 |
| Deferred License Revenue - Current | — | 46 |
| Insurance Financing Note Payable | 264 | 268 |
| Customer Deposits | 356 | 97 |
| Total Current Liabilities | 9,580 | 14,091 |
| Lease Liabilities - Operating - Long-Term | 1,454 | 1,699 |
| Lease Liabilities - Finance - Long-Term | 304 | 931 |
| Term Loans - Long-Term, Net of Issuance Costs | 8,826 | 8,472 |
| Deferred License Revenue - Long-Term | — | 429 |
| Deferred Consideration - Long-Term | — | 1,000 |
| Total Liabilities | 20,164 | 26,622 |
| Commitments and Contingencies (See Note 14) | ||
| Stockholders’ Equity: | ||
| Preferred Stock, $0.0001 par value, 2,000,000 shares authorized, 15,000 shares issued and outstanding at both December 31, 2025 and 2024 | — | — |
| Common Stock, $0.0001 par value, 170,000,000 shares authorized, 39,405,302 and 34,056,920 shares issued and outstanding at December 31, 2025 and 2024, respectively | 4 | 3 |
| Additional Paid-in Capital | 439,838 | 430,207 |
| Accumulated Deficit | (402,992) | (397,678) |
| Accumulated Other Comprehensive Income | 131 | 54 |
| Total Stockholders’ Equity | 36,981 | 32,586 |
| Total Liabilities and Stockholders’ Equity | $57,145 | $59,208 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.